Clinical Research Directory
Browse clinical research sites, groups, and studies.
Utilizing Anti-Factor Xa as a Predictive Tool for Optimizing Outcome in Burn Patients' Management
Sponsor: Ain Shams University
Summary
This study aims to compare the efficacy of anti-Xa based versus weight-based enoxaparin dosing and to evaluate anti-Xa levels as a predictive tool for clinical outcomes in burn patients
Key Details
Gender
All
Age Range
21 Years - Any
Study Type
INTERVENTIONAL
Enrollment
25
Start Date
2025-11-28
Completion Date
2027-11-30
Last Updated
2026-03-11
Healthy Volunteers
No
Conditions
Interventions
follow up venous thrombo embolic events with routine clexan dose modification guided by anti factor 10 assay
follow up vte incidence and routine clexan dose modification
follow up venous thromboembolic events with no routine clexan dosage modification and no usage of anti factor 10 assay
follow up of vte incidence with no routine dose modification unless indicated
Locations (1)
Ain Shams University
Cairo, Abbassia, Egypt